
-
2004
Company Description
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
ProMIS Neurosciences is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).
-
Manufacturer:
Science and Engineering -
Formed:
2004 -
Company Website:
-
Company E-mail:
-
Company Address:
1920 Yonge Street, Suite 200Toronto, ONCanada -
CEO:
- Elliot Goldstein
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits